Top pharma companies, through its association IPA, has written to the DCGI, calling the current process "outdated". The industry has recommended a few changes in the procedure such as "validating the genuineness" of the drugs and issuing of showcause notice before making a public announcement
According to industry experts, once the drug features in the list - along with the batch number, manufacturing date and expiry date - the company recalls the entire batch and destroys it
New Delhi: The central and state drug regulatory bodies have banned the licences of numerous production facilities and revoked the product approvals of a few others, all on the grounds of quality.
The decision by the DGCA was taken after it examined 76 enterprises across 20 states and union territories, with close to 203 firms being identified for review.
DGCI cancels license of 18 pharma companies theindianawaaz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theindianawaaz.com Daily Mail and Mail on Sunday newspapers.